로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > IDH1

IDH1

요약

Name:Isocitrate dehydrogenase [NADP] cytoplasmic
Target Synonym:IDH,EC 1.1.1.42,PICD,IDCD,Isocitrate Dehydrogenase (NADP(+)) 1,Isocitrate Dehydrogenase 1 (NADP+), Soluble,HEL-S-26,IDH1,Isocitrate Dehydrogenase (NADP(+)) 1, Cytosolic,HEL-216,NADP(+)-Specific ICDH,Cytosolic NADP-Isocitrate Dehydrogenase,IDP,NADP-Dependent Isocitrate Dehydrogenase, Cytosolic,Oxalosuccinate Decarboxylase,Epididymis Secretory Protein Li 26,Isocitrate Dehydrogenase 1 (NADP+),NADP-Dependent Isocitrate Dehydrogenase, Peroxisomal,IDPC,EC:1.1.1.42,Epididymis Luminal Protein 216,Epidid
Number of Launched Drugs:2
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Approved

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
태그별:
결합물별:
제품번호 제품 설명 구조 순도 특징
ID1-H51H8 Human Human IDH1 (R132C) Protein, His Tag (MALS verified)
ID1-H51H8-structure
ID1-H51H8-sds
ID1-H51H6 Human Human IDH1 Protein, His Tag (active enzyme, MALS verified)
ID1-H51H6-structure
ID1-H51H6-sds

일부의 생물활성 데이터

ID1-H51H8-MALS-HPLC
IDH1 MALS images

The purity of Human IDH1 (R132C), His Tag (Cat. No. ID1-H51H8) is more than 85% and the molecular weight of this protein is around 85-100 kDa verified by SEC-MALS.

ID1-H51H6-MALS-HPLC
IDH1 MALS images

The purity of Human IDH1, His Tag (Cat. No. ID1-H51H6) is more than 85% and the molecular weight of this protein is around 90-100 kDa verified by SEC-MALS.

Synonym Name

IDH1,PICD,IDP

Background

Isocitrate dehydrogenase 1 (IDH1) is also known as Cytosolic NADP-isocitrate dehydrogenase (NADP(+)-specific ICDH), Oxalosuccinate decarboxylase and PICD, which is one of the Isocitrate dehydrogenases that can catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD+ as the electron acceptor and the other NADP+. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Ivosidenib AG-120; CS-3010; S-95031; CS 3010 Approved Agios Pharmaceuticals Inc Tibsovo, 拓舒沃, Tidhesco, Tuoshuvo, TIBSOVO, Tosuvo United States Leukemia, Myeloid, Acute Servier Pharmaceuticals Llc 2018-07-20 Histiocytosis, Langerhans-Cell; Neuroectodermal Tumors, Primitive, Peripheral; Neoplasms, Germ Cell and Embryonal; Lymphoma, Non-Hodgkin; Neoplasms, Neuroepithelial; Glioma; Leukemia, Myeloid, Acute; Bile Duct Neoplasms; Hepatic Insufficiency; Osteosarcoma; Sarcoma, Ewing; Cholangiocarcinoma; Pancytopenia; Sarcoma; Neuroblastoma; Ependymoma; Wilms Tumor; Sarcoma, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Disorders; Rhabdoid Tumor; Hepatoblastoma; Solid tumours; Rhabdomyosarcoma; Medulloblastoma; Chondrosarcoma; Hematologic Neoplasms; Leukemia; Leukemia, Myeloid Details
Olutasidenib FT-2102 Approved Forma Therapeutics Inc Rezlidhia United States Leukemia, Myeloid, Acute Rigel Pharmaceuticals Inc 2022-12-01 Chondrosarcoma; Leukemia, Promyelocytic, Acute; Irritable Bowel Syndrome; Myelodysplastic Syndromes; Diarrhea; Leukemia, Myeloid, Acute Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
TQB-3454 TQB-3454; CT-2755 Phase 3 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd Hematologic Neoplasms; Solid tumours; Biliary Tract Neoplasms; Myelodysplastic Syndromes; Bile Duct Neoplasms; Leukemia, Myeloid, Acute Details
HMPL-306 HMPL-306 Phase 1 Clinical Hutchison Medipharma Ltd Hematologic Neoplasms; Solid tumours; Neoplasms; Leukemia, Myeloid, Acute Details
BAY-1436032 BAY-1436032 Phase 1 Clinical Bayer AG Solid tumours; Neoplasms; Leukemia, Myeloid, Acute Details
TQB-3455 TQB-3455; CT-2426 Phase 1 Clinical Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Lianyungang Runzhong Pharmaceutical Co Ltd, Beijing Centaurus Biopharma Co Ltd Hematologic Neoplasms; Solid tumours; Neoplasms; Leukemia, Myeloid, Acute Details
LY-3410738 LY-3410738 Phase 1 Clinical Eli Lilly And Company Solid tumours; Chondrosarcoma; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Myeloproliferative Disorders; Cholangiocarcinoma; Leukemia, Myeloid, Acute; Glioma Details
KY-100001 KY-100001 Phase 1 Clinical Kpc Pharmaceuticals Inc Solid tumours Details
IDH-305 IDH-305 Phase 1 Clinical Novartis Pharma Ag Neoplasms; Leukemia, Myeloid, Acute; Glioma Details
Safusidenib DS-1001b; DS-1001; AB-218 Phase 2 Clinical Daiichi Sankyo Co Ltd Solid tumours; Biliary Tract Neoplasms; Glioma Details
HH-2301 HH-2301; HH2301 Phase 1 Clinical ShangHai HaiHe Biopharma Co Ltd Biliary Tract Neoplasms; Solid tumours; Chondrosarcoma; Glioma Details
Vorasidenib AG-881 Phase 3 Clinical Agios Pharmaceuticals Inc, Laboratoires Servier, Celgene Corp Hematologic Neoplasms; Myelodysplastic Syndromes; Astrocytoma; Hepatic Insufficiency; Glioma; Leukemia, Myeloid, Acute Details

This web search service is supported by Google Inc.

totop